Lexagene Holdings Inc LXXGQ

Healthcare Medical Devices

Lexagene Holdings Inc. is a molecular diagnostics company engaged in researching, developing and commercializing automated genetic analyzer devices in clinical and life science industries. The Company is focused on developing molecular diagnostic systems for pathogen detection and genetic testing for other molecular markers for on-site rapid testing in veterinary diagnostics, and for use in open-access markets such as food and water safety, clinical research, agricultural testing and biodefense. The Company's MiQLab System is an automated, open-access molecular diagnostic system for pathogen detection, allowing users to test for multiple pathogens onsite, returning results in approximately 2 hours. Its MiQLab System is an automated, multiplexing polymerase chain reaction (PCR)-based system designed for syndromic testing in human clinical diagnostics and veterinary diagnostics, as well as food safety testing, and open-access custom testing markets.

GREY:LXXGQ - Post by User

Lexagene Holdings Inc > Investor conference of small-cap public companies

<< Previous

Bullboard Posts

Next >>

Post by TanzaniteMotherLodeon Sep 02, 2020 10:49am

180 Views

Post# 31493803

Investor conference of small-cap public companies

Since making investor relations history in 1989 for being the first to webcast an investor conference, The Wall Street Investor Forum has continued to bridge the investor conference gap between public companies and investors. In the midst of a pandemic, The Forum is committed to serving companies and investors during this time of uncertainty. Industries featured in the Q3 investor conference include: Biotechnology, Medical Device, Clean Technology, Mining & Metals, Oil & Gas, Water, and Healthcare.

LEXAGENE TO PRESENT 10AM EST Thursday Sept 10, 2020

https://investor-conference.com/schedule/

<< Previous

Bullboard Posts

Next >>

Advancing flagship Ishkõday Gold Project in Ontario